SCHEMBL5048950

SCHEMBL5048950

NC(=S)c1ccccc1-c1ccccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.47
DPP4 P27487 1/20 0.44
CYP2A6 P11509 1/20 0.41
CES2 O00748 1/20 0.40
CES1 P23141 1/20 0.40
PLA2G7 Q13093 1/20 0.39
ALDH1A1 P00352 3/20 0.39
PARP1 P09874 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
LMNA P02545 2/20 0.38
MGLL Q99685 1/20 0.37
RECQL P46063 1/20 0.37
POLB P06746 1/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
HTR3A P46098 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13964794 0.87 BCAT2 (0.43) PKMALDH1A1TP53HPGDKDM4E
SCHEMBL1335840 0.82 CES2 (0.52) PKMCES2CES1ALDH1A1NPC1
SCHEMBL31016401 0.82 CES2 (0.52) PKMCES2CES1ALDH1A1NPC1
SCHEMBL27501743 0.81 CYP2A6 (0.48) PKMDPP4CYP2A6CES2CES1
SCHEMBL29940950 0.79 BCAT2 (0.59) CES2CES1ALDH1A1PARP1SMN1; SMN2
SCHEMBL1203519 0.79 BCAT2 (0.59) CES2CES1ALDH1A1PARP1SMN1; SMN2
SCHEMBL8343625 0.76 SLC6A4 (0.53) ALDH1A1PARP1NPC1RAB9AMAPT
SCHEMBL28176247 0.75 L3MBTL1 (0.42) ALDH1A1RAB9APOLBHPGDKDM4E
SCHEMBL709834 0.74 BCAT2 (0.63) DPP4ALDH1A1PARP1SMN1; SMN2RECQL
SCHEMBL3537227 0.74 TSHR (0.54) PKMCES2CES1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-B1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP disclosed
CN-100360527-C CB 1 receptor inverse agonists HOFFMANN LA ROCHE (CH) 2008-01-09 CN disclosed
US-7135488-B2 Pyrrolyl-thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2006-11-14 US disclosed
CN-1735611-A CB 1 receptor inverse agonists HOFFMANN LA ROCHE (CH) 2006-02-15 CN disclosed
EP-1583762-A1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-12 EP disclosed
US-20040147572-A1 Novel pyrrolyl-thiazole derivatives HOFFMAN-LA ROCHE INC. 2004-07-29 US disclosed
WO-2004060888-A1 NOVEL CB 1 RECEPTOR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2004-07-22 WO disclosed
CN-1054803-C Polycarbonic acid ester resin layered products absorbing near-infrared and formed products made of same DAICEL CHEM (JP) 2000-07-26 CN disclosed
CN-1094354-A Polycarbonate-based resin laminate of absorption near infrared ray and formed body thereof DAICEL CHEM (JP) 1994-11-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147572-A1 Novel pyrrolyl-thiazole derivatives CNR1, CNR2, NPY1R PKM 2463/4885DPP4 2177/4885CYP2A6 781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.